Clinical Trials on Cavernous Angioma, Familial in Belgium

Total 105 results

Antwerp Cardiovascular Institute Middelheim

Completed

RRISC Study: Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent.

Coronary Artery Disease | Stable Angina | Unstable Angina | Saphenous Vein Graft Disease

Belgium
University Hospital, Antwerp

Recruiting

ReACHallenge Trial: Acetylcholine Rechallenge After Pretreatment With Vasoactive Drugs (ReACHallenge)

Angina Pectoris, Variant | Angina Pectoris; Spasm-Induced | Angina Pectoris With Normal Coronary Arteriogram

Belgium
Ziekenhuis Oost-Limburg

Completed

Time Gain in the Diagnosis Myocardial Infarction by Troponin Point of Care Testing in the Emergency Room (T-POCT)

Angina, Stable | Angina Pectoris | Angina, Unstable | Non STEMI | Angina, Prinzmetal's

Belgium
UMC Utrecht

Completed

Drug-eluting Balloon in Bifurcations Trial (DEBIUT)

Coronary Artery Disease | Atherosclerosis | Stable Angina | Unstable Angina

Netherlands, Belgium
Therabel Pharma SA/NV

Completed

Effect of Molsidomine on the Endothelial (Internal Layer of Blood Vessels) Dysfunction in Patients With Angina Pectoris (MEDCOR)

Atherosclerosis | Stable Angina Pectoris

Belgium
CoreAalst BV
Abbott Medical Devices

Recruiting

Exercise and Coronary Microvascular Disease (ExerciseCMD)

Coronary Microvascular Disease

Belgium
CoreAalst BV
Hexacath, France

Recruiting

The Euro-CRAFT Registry (Euro-CRAFT)

Coronary Microvascular Disease

Netherlands, Belgium, Spain
CID - Carbostent & Implantable Devices

Completed

International Randomized Comparison Between DES Limus Carbostent and Taxus DES in the Treatment of De-novo Coronary Lesions (NEXT)

Stable Angina | Unstable Angina | Documented Silent Ischemia

France, Germany, Belgium, Italy
Universitaire Ziekenhuizen KU Leuven

Unknown

Physiopathology of Pulmonary Arterial Hypertension: Mechanistic Studies

Idiopathic Pulmonary Arterial Hypertension

Belgium
Biopure Corporation

Completed

Pilot Study of Hemoglobin Based Oxygen Therapeutics in Elective Coronary Revascularization

Myocardial Infarction | Angina Pectoris | Unstable Angina

Belgium, Germany, Netherlands
AstraZeneca

Completed

A Study to Evaluate the Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia

Homozygous Familial Hypercholesterolemia (HoFH)

Malaysia, Canada, Taiwan, Belgium, Denmark, Israel
Maastricht University Medical Center
FABPulous B.V.

Completed

Incremental Value of Point of Care H-FABP Testing in Primary Care Patients Suspected of Acute Coronary Syndrome (RAPIDA)

Acute Coronary Syndrome | Thoracic Diseases | Angina Pectoris, Stable | Angina Pectoris, Unstable

Belgium, Netherlands
AstraZeneca

Completed

A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia (HYDRA)

Homozygous Familial Hypercholesterolemia (HoFH)

Malaysia, Canada, Israel, Netherlands, Taiwan, Belgium, Denmark
Université Libre de Bruxelles

Terminated

Hyperoxia and Microvascular Dysfunction

Ischemic Heart Disease | Coronary Microvascular Disease | Microvascular Disease

Belgium
AstraZeneca

Completed

An Study to Evaluate Rosuvastatin in Children and Adolescents With Familial Hypercholesterolaemia

Familial Hypercholesterolaemia

United States, Netherlands, Norway, Canada, Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions

Pulmonary Arterial Hypertension | Heart Defects, Congenital | Genetic Testing

Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

CT Perfusion Added to CT Angiography (PERFeCT)

Angina Pectoris

Belgium
Neovasc Inc.

Completed

Coronary Sinus Reducer for Treatment of Refractory Angina - COSIRA (COSIRA)

Refractory Angina

United Kingdom, Canada, Belgium, Denmark, Netherlands, Sweden
Mirum Pharmaceuticals, Inc.

Active, not recruiting

An Extension Study of Maralixibat in Patients With Progressive Familial Intrahepatic Cholestasis (PFIC)

Progressive Familial Intrahepatic Cholestasis (PFIC)

United States, Argentina, France, Singapore, United Kingdom, Belgium, Turkey, Austria, Brazil, Canada, Colombia, Germany, Italy, Lebanon, Mexico, Poland
Akcea Therapeutics
Ionis Pharmaceuticals, Inc.

Terminated

The BROADEN Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Partial Lipodystrophy

Familial Partial Lipodystrophy

United States, Netherlands, Belgium, Brazil, Canada, Germany, Russian Federation
Mirum Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC) (MARCH-PFIC)

Progressive Familial Intrahepatic Cholestasis (PFIC)

Italy, United States, Argentina, France, Singapore, United Kingdom, Austria, Brazil, Mexico, Lebanon, Germany, Turkey, Poland, Belgium, Canada, Colombia, Hungary
CID - Carbostent & Implantable Devices

Completed

Clinical Performance of CRE8 Drug Eluting Stent in All Comer Population (PARTICIPATE)

Stable Angina | Acute Myocardial Infarction | Unstable Angina

Austria, Italy, Netherlands, Belgium, Norway, Poland
Thorax Centrum Twente

Unknown

Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents (BIONYX)

Coronary Artery Disease | Angina Pectoris | Acute Coronary Syndrome | Unstable Angina Pectoris | Coronary Stenosis | Coronary Restenosis

Netherlands, Israel, Belgium
Lung Biotechnology PBC

Completed

An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients

Pulmonary Arterial Hypertension

United States, Belgium, Ireland
Ziekenhuis Netwerk Antwerpen (ZNA)

Recruiting

Observational Registry on Clinical Outcome After Diagnosis of Chronic Total Occlusions (PETS-CTO)

Angina Pectoris | Chronic Total Occlusion of Coronary Artery

Belgium
Mitsubishi Tanabe Pharma Corporation

Completed

Study on Safety and Effectiveness of Three Doses of Argatroban as Anticoagulant in Percutaneous Coronary Intervention (PCI)

Coronary Artery Disease | Angina, Unstable

Belgium, Germany
Neovasc Inc.
Shockwave Medical, Inc.

Active, not recruiting

REDUCER-I: An Observational Study of the Neovasc Reducer™ System

Angina Pectoris | Chronic Stable Angina | Angina Pectoris, Stable

Netherlands, Spain, United Kingdom, Germany, Italy, Switzerland, Belgium, France, Austria
Alnylam Pharmaceuticals

Completed

ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)

Amyloid Neuropathies | Amyloid Neuropathies, Familial | Amyloidosis, Hereditary | Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC) | Amyloidosis, Hereditary, Transthyretin-Related | Familial Transthyretin Cardiac Amyloidosis

United States, France, Italy, Spain, Canada, Germany, Belgium, Sweden, United Kingdom
Amgen

Completed

Trial Evaluating PCSK9 Antibody in Subjects With LDL Receptor Abnormalities (TESLA)

Homozygous Familial Hypercholesterolemia

New Zealand, South Africa, France, United States, Spain, Belgium, Czechia, Italy, Netherlands, Hong Kong, Canada, Lebanon
Brugmann University Hospital

Completed

Evaluation of New Markers in Type 3 Angioedema

Angio Edema

Belgium
Ablynx, a Sanofi company

Completed

Comparative Study of ALX-0081 Versus GPIIb/IIIa Inhibitor in High Risk Percutaneous Coronary Intervention (PCI) Patients

Unstable Angina | Non ST Segment Elevation Myocardial Infarction (NSTEMI) | Stable Angina (Associated With High Risk PCI)

Poland, Belgium, Germany, Israel, Austria, Switzerland, Czechia
Actelion

Completed

Epoprostenol for Injection (EFI/ACT-385781A) - Pulmonary Arterial Hypertension (EPITOME-2)

Pulmonary Arterial Hypertension

Spain, Belgium, France, Canada, Italy, Netherlands
Actelion
Chiltern International Ltd.; Effi-Stat

Completed

Epoprostenol for Injection in Patients With Pulmonary Arterial Hypertension (Epitome2ext)

Pulmonary Arterial Hypertension

France, Spain, Netherlands, Belgium, Canada, Italy
Actelion

Completed

Study of ACT-293987 (NS-304) in Pulmonary Arterial Hypertension (PAH)

Pulmonary Arterial Hypertension

United Kingdom, Austria, Belgium, France, Germany, Hungary, Italy, Poland
Amgen

Completed

Safety, Tolerability and Efficacy of Evolocumab (AMG 145) in Children With Inherited Elevated Low-density Lipoprotein Cholesterol (Familial Hypercholesterolemia) (HAUSER-OLE)

Familial Hypercholesterolemia

Canada, Italy, Norway, Belgium, United States, Turkey, Australia, Austria, South Africa, Poland, Switzerland, Spain, Portugal, Slovenia, Brazil, Russian Federation, Hungary, United Kingdom, Colombia, Czechia, Netherlands, Greece, Ma...
Novartis Pharmaceuticals

Terminated

Extension to CQTI571A2102 to Evaluate Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH)

Pulmonary Arterial Hypertension

Germany, Belgium, United Kingdom, United States, Lithuania, Italy, Australia
Amgen

Completed

Trial Assessing Long Term USe of PCSK9 Inhibition in Subjects With Genetic LDL Disorders (TAUSSIG)

Severe Familial Hypercholesterolemia

Italy, Czechia, United States, Israel, New Zealand, South Africa, France, Spain, Australia, Belgium, Canada, Netherlands, Hong Kong, Brazil, United Kingdom, Greece, Japan, Lebanon
CeloNova BioSciences, Inc.

Unknown

Randomized Trial of COBRA PzF Stenting to Reduce Duration of Triple Therapy (COBRA-REDUCE)

Angina, Stable | Angina, Unstable | Anticoagulants

United States, Denmark, France, Germany, Belgium, Italy, Latvia, Switzerland
KU Leuven
Hasselt University; Jessa Hospital

Completed

Telerehabilitation in Coronary Heart Disease (TRiCH)

Myocardial Infarction | Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)) | Percutaneous Transluminal Cutting Balloon Angioplasty of Popliteal Vein Using Fluoroscopic Guidance

Belgium
Amgen

Completed

Trial Assessing Efficacy, Safety and Tolerability of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition in Paediatric Subjects With Genetic Low-Density Lipoprotein (LDL) Disorders (HAUSER-RCT)

Heterozygous Familial Hypercholesterolemia

United States, Canada, Italy, Norway, Belgium, Turkey, Australia, New Zealand, Austria, Czechia, South Africa, Poland, Spain, Switzerland, Netherlands, Taiwan, Finland, Brazil, Portugal, Slovenia, Russian Federation, Hungary, United... and more
Novartis Pharmaceuticals

Completed

Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Participants

Pulmonary Arterial Hypertension

Germany, Belgium, United States, Lithuania, United Kingdom, Italy, Australia
Lung Biotechnology PBC

Completed

Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)

Pulmonary Arterial Hypertension

United States, Belgium, Czechia, Germany, Ireland, Romania
Kastle Therapeutics, LLC

Completed

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol (FOCUS FH)

Hypercholesterolemia | Heterozygous Familial

United States, Italy, Poland, Ukraine, United Kingdom, Germany, Hong Kong, Taiwan, Spain, Argentina, Belgium, Israel, Malaysia, South Africa, Turkey, Netherlands, Korea, Republic of, Canada, New Zealand, Russian Federation, Brazil, Austral... and more
Arrowhead Pharmaceuticals

Active, not recruiting

Study of ARO-APOC3 (Plozasiran) in Adults With Familial Chylomicronemia Syndrome (FCS) (PALISADE)

Familial Chylomicronemia

Korea, Republic of, Canada, Australia, Singapore, Belgium, Spain, Japan, United States, Austria, Germany, Ireland, Oman, Poland, Israel, New Zealand, Argentina, France, Croatia, Mexico, Serbia, Turkey
Lung Biotechnology PBC

Completed

Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients

Pulmonary Arterial Hypertension

United States, Belgium, Czechia, Germany, Ireland, Romania
Universitaire Ziekenhuizen KU Leuven

Completed

Registry With Information About Colitis Ulcerosa and Familial Adenomatous Polyposis Patients (KOPOF)

Adenomatous Polyposis Coli | Colitis,Ulcerative | Reservoir, Ileoanal

Belgium
Albireo

Active, not recruiting

Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC

Progressive Familial Intrahepatic Cholestasis

United States, Spain, Netherlands, United Kingdom, Turkey, Canada, Italy, Germany, France, Israel, Australia, Belgium, Poland, Saudi Arabia, Sweden
Centre Hospitalier Universitaire de Liege
Sanofi; Takeda; University of Liege; Orchard Therapeutics; Centre Hospitalier Régional... and other collaborators

Recruiting

Baby Detect : Genomic Newborn Screening

Congenital Adrenal Hyperplasia | Hemophilia A | Hemophilia B | Mucopolysaccharidosis I | Mucopolysaccharidosis II | Cystic Fibrosis | Alpha 1-Antitrypsin Deficiency | Sickle Cell Disease | Fanconi Anemia | Chronic Granulomatous Disease | Wilson Disease | Severe Congenital Neutropenia | Ornithine Transcarbamylase... and other conditions

Belgium
Alnylam Pharmaceuticals

Active, not recruiting

HELIOS-A: A Study of Vutrisiran (ALN-TTRSC02) in Patients With Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis)

Transthyretin Amyloidosis | Amyloidosis, Hereditary

United States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Cyprus, France, Germany, Greece, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Netherlands, Portugal, Spain, Sweden, Taiwan, United Kingdom
Ceric Sàrl
Boston Scientific Corporation

Completed

Efficacy and Safety of New Generation Drug Eluting Stents Associated With an Ultra Short Duration of Dual Antiplatelet Therapy. Design of the Short Duration of Dual antiplatElet Therapy With SyNergy II Stent in Patients Older Than 75 Years Undergoing Percutaneous Coronary Revascularization. (SENIOR)

Acute Coronary Syndrome | Stable Angina | Silent Myocardial Ischemia

France, Spain, Belgium, Switzerland, United Kingdom, Latvia, Finland, Italy, North Macedonia

Clinical Trials on Cavernous Angioma, Familial in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Paraguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations